Chedraui P - Search Results

1

Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17β-estradiol/progesterone.

Cortés-Bonilla M, Alonso-Campero R, Bernardo-Escudero R, Francisco-Doce MT, Chavarín-González J, Pérez-Cuevas R, Chedraui P. Cortés-Bonilla M, et al. Among authors: chedraui p. Gynecol Endocrinol. 2016 Oct;32(10):831-834. doi: 10.1080/09513590.2016.1183628. Epub 2016 May 17. Gynecol Endocrinol. 2016. PMID: 27187320 Clinical Trial.

2

The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study.

Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. Hidalgo LA, et al. Gynecol Endocrinol. 2005 Nov;21(5):257-64. doi: 10.1080/09513590500361192. Gynecol Endocrinol. 2005. PMID: 16373244 Clinical Trial.

3

The metabolic syndrome among postmenopausal women in Ecuador.

Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. Hidalgo LA, et al. Gynecol Endocrinol. 2006 Aug;22(8):447-54. doi: 10.1080/09513590600890272. Gynecol Endocrinol. 2006. PMID: 17012107

4

Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index.

Chedraui P, San Miguel G, Hidalgo L, Morocho N, Ross S. Chedraui P, et al. Gynecol Endocrinol. 2008 Nov;24(11):620-4. doi: 10.1080/09513590802288283. Gynecol Endocrinol. 2008. PMID: 19031218 Clinical Trial.

5

Quality of life impairment during the female menopausal transition is related to personal and partner factors.

Chedraui P, San Miguel G, Avila C. Chedraui P, et al. Gynecol Endocrinol. 2009 Feb;25(2):130-5. doi: 10.1080/09513590802617770. Gynecol Endocrinol. 2009. PMID: 19253110

6

Quality of life impairment among postmenopausal women varies according to race.

Monterrosa A, Blumel JE, Chedraui P, Gomez B, Valdez C. Monterrosa A, et al. Among authors: chedraui p. Gynecol Endocrinol. 2009 Aug;25(8):491-7. doi: 10.1080/09513590902972091. Gynecol Endocrinol. 2009. PMID: 19903056

7

Hyperglycemia in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaints.

Chedraui P, Pérez-López FR, Blümel JE, Hidalgo L, Barriga J. Chedraui P, et al. Gynecol Endocrinol. 2010 Feb;26(2):86-92. doi: 10.3109/09513590903184092. Gynecol Endocrinol. 2010. PMID: 19908936

8

Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens.

Pérez-López FR, Cuadros-López JL, Fernández-Alonso AM, Cuadros-Celorrio AM, Sabatel-López RM, Chedraui P. Pérez-López FR, et al. Among authors: chedraui p. Gynecol Endocrinol. 2010 Jul;26(7):533-8. doi: 10.3109/09513590903367028. Gynecol Endocrinol. 2010. PMID: 19916873

9

Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes.

Aguirre W, Chedraui P, Mendoza J, Ruilova I. Aguirre W, et al. Among authors: chedraui p. Gynecol Endocrinol. 2010 May;26(5):333-7. doi: 10.3109/09513590903511539. Gynecol Endocrinol. 2010. PMID: 20050764 Clinical Trial.

10

Metabolic and hormonal parameters in post-menopausal women 10 years after transdermal oestradiol treatment, alone or combined to micronized oral progesterone.

Cuadros JL, Fernández-Alonso AM, Chedraui P, Cuadros AM, Sabatel RM, Pérez-López FR. Cuadros JL, et al. Among authors: chedraui p. Gynecol Endocrinol. 2011 Mar;27(3):156-62. doi: 10.3109/09513590.2010.487613. Epub 2010 May 26. Gynecol Endocrinol. 2011. PMID: 20500105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page